Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bhavna Verma

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Cureus|December 4, 2023
Surgical Site Infections in Elective and Emergency Abdominal Surgeries: A Prospective Observational Study About Incidence, Risk Factors, Pathogens, and Antibiotic Sensitivity at a Government Tertiary Care Teaching Hospital in IndiaHimanshu Jatoliya, Rajendra K Pipal, Dharmendra K Pipal, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 13, 2010
TCR mimic monoclonal antibody targets a specific peptide/HLA class I complex and significantly impedes tumor growth in vivo using breast cancer modelsBhavna Verma, Francisca A Neethling, Shannon Caseltine, et al.
Cancer Immunology, Immunotherapy : CII|September 26, 2009
Direct discovery and validation of a peptide/MHC epitope expressed in primary human breast cancer cells using a TCRm monoclonal antibody with profound antitumor propertiesBhavna Verma, Oriana E Hawkins, Francisca A Neethling, et al.
International Journal of Molecular Sciences|June 13, 2025
Feasibility Assessment of Autologous Human Immune System (HIS) ImmunoGraft Platform Development Using Autologous Mobilized Peripheral Blood (MPB) CD34 Cells Derived from Adult HNSCC PatientBhavna Verma, Georgia Zhuo Chen, Edmund K Waller, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 2, 2011
TCR mimic monoclonal antibodies induce apoptosis of tumor cells via immune effector-independent mechanismsBhavna Verma, Rinki Jain, Shannon Caseltine, et al.
Cancer Research|January 14, 2017
Radiation-Induced Enhancement of Antitumor T-cell Immunity by VEGF-Targeted 4-1BB CostimulationBrett Schrand, Bhavna Verma, Agata Levay, et al.
The Prostate|November 18, 2014
Forced LIGHT expression in prostate tumors overcomes Treg mediated immunosuppression and synergizes with a prostate tumor therapeutic vaccine by recruiting effector T lymphocytesLisa Yan, Diane M Da Silva, Bhavna Verma, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 26, 2011
An HLA-presented fragment of macrophage migration inhibitory factor is a therapeutic target for invasive breast cancerOriana Hawkins, Bhavna Verma, Stanley Lightfoot, et al.
The EMBO Journal|July 17, 2025
Amyloid-β disrupts APP-regulated protein aggregation and dissociation from recycling endosomal membranesPreman J Singh, Bhavna Verma, Adam Wells, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cureus|December 4, 2023
Surgical Site Infections in Elective and Emergency Abdominal Surgeries: A Prospective Observational Study About Incidence, Risk Factors, Pathogens, and Antibiotic Sensitivity at a Government Tertiary Care Teaching Hospital in IndiaHimanshu Jatoliya, Rajendra K Pipal, Dharmendra K Pipal, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 13, 2010
TCR mimic monoclonal antibody targets a specific peptide/HLA class I complex and significantly impedes tumor growth in vivo using breast cancer modelsBhavna Verma, Francisca A Neethling, Shannon Caseltine, et al.
Cancer Immunology, Immunotherapy : CII|September 26, 2009
Direct discovery and validation of a peptide/MHC epitope expressed in primary human breast cancer cells using a TCRm monoclonal antibody with profound antitumor propertiesBhavna Verma, Oriana E Hawkins, Francisca A Neethling, et al.
International Journal of Molecular Sciences|June 13, 2025
Feasibility Assessment of Autologous Human Immune System (HIS) ImmunoGraft Platform Development Using Autologous Mobilized Peripheral Blood (MPB) CD34 Cells Derived from Adult HNSCC PatientBhavna Verma, Georgia Zhuo Chen, Edmund K Waller, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 2, 2011
TCR mimic monoclonal antibodies induce apoptosis of tumor cells via immune effector-independent mechanismsBhavna Verma, Rinki Jain, Shannon Caseltine, et al.
Cancer Research|January 14, 2017
Radiation-Induced Enhancement of Antitumor T-cell Immunity by VEGF-Targeted 4-1BB CostimulationBrett Schrand, Bhavna Verma, Agata Levay, et al.
The Prostate|November 18, 2014
Forced LIGHT expression in prostate tumors overcomes Treg mediated immunosuppression and synergizes with a prostate tumor therapeutic vaccine by recruiting effector T lymphocytesLisa Yan, Diane M Da Silva, Bhavna Verma, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 26, 2011
An HLA-presented fragment of macrophage migration inhibitory factor is a therapeutic target for invasive breast cancerOriana Hawkins, Bhavna Verma, Stanley Lightfoot, et al.
The EMBO Journal|July 17, 2025
Amyloid-β disrupts APP-regulated protein aggregation and dissociation from recycling endosomal membranesPreman J Singh, Bhavna Verma, Adam Wells, et al.
Pageof 2